Premium
Deficiency of a cholinergic differentiating factor in fibroblasts of patients with Alzheimer's disease
Author(s) -
Kessler John A.
Publication year - 1987
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.410210117
Subject(s) - cholinergic , endocrinology , medicine , fibroblast , cholinergic neuron , pathophysiology , alzheimer's disease , disease , secretion , basic fibroblast growth factor , degenerative disease , acetylcholine , nerve growth factor , biology , growth factor , cell culture , receptor , genetics
Skin fibroblasts from patients with Alzheimer's disease and from apparently normal control subjects were compared for their production of a cholinergic differentiating factor. The factor's activity was assayed by measuring the induction of choline acetltransferase (CAT) activity in cultured sympathetic neurons. Culture medium conditioned by exposure to normal human fibroblasts induced substantial levles of CAT activity in sympathetic neurons, indicating that human fibroblasts produce a soluble factor that promotes cholinergic expression. In contrast, medium conditioned by Alzheimer fibroblasts induced only about one‐third as much CAT activity, a highly significant reduction ( p < 0.01). These observations suggest that Alzheimer fibroblasts may be deficient in their secretion of a cholinergic factor and raise the possibility that the pathophysiology of the disease is related to a defect in the release of this factor. The fibroblast abnormalities suggest that Alzheimer's disease may be a systemic disease involving nonneuronal cells that are outside as well as within the brain.